These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vancomycin dosing in children and young adults: back to the drawing board. Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205 [TBL] [Abstract][Full Text] [Related]
4. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Eiland LS; English TM; Eiland EH Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865 [TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children. Sridharan K; Abbasi MY; Mulubwa M Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):539-546. PubMed ID: 34156647 [TBL] [Abstract][Full Text] [Related]
6. Drug use density in critically ill children and newborns: analysis of various methodologies. Valcourt K; Norozian F; Lee H; Raszynski A; Torbati D; Totapally BR Pediatr Crit Care Med; 2009 Jul; 10(4):495-9. PubMed ID: 19451853 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of vancomycin in children hospitalized in a critical care unit]. Acuña C; Morales J; Castillo C; Torres JP Rev Chilena Infectol; 2013 Dec; 30(6):585-90. PubMed ID: 24522298 [TBL] [Abstract][Full Text] [Related]
8. [Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit]. Villena R; González CA; Nalegach ME; Vásquez A; Villareal M; Drago M Rev Chilena Infectol; 2014 Jun; 31(3):249-53. PubMed ID: 25146197 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic monitoring of vancomycin in critical care pediatric patients]. Zylbersztajn BL; Travaglianti M; Weller G; Mato HG Arch Argent Pediatr; 2008 Feb; 106(1):26-31. PubMed ID: 18636130 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis. Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients. Mar Fernández de Gatta MD; Victoria Calvo M; Ardanuy R; Domínguez-Gil A; Lanao JM; Moreno SR J Pharm Pharmacol; 2009 Jun; 61(6):759-66. PubMed ID: 19505366 [TBL] [Abstract][Full Text] [Related]
12. Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children. Genuini M; Oualha M; Bouazza N; Moulin F; Treluyer JM; Lesage F; Renolleau S; Benaboud S Pediatr Crit Care Med; 2018 Jun; 19(6):e263-e269. PubMed ID: 29394210 [TBL] [Abstract][Full Text] [Related]
13. Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness. Lopez SA; Mulla H; Durward A; Tibby SM Pediatr Crit Care Med; 2010 Mar; 11(2):267-74. PubMed ID: 19770786 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients. Jung D; Kishk OA; Bhutta AT; Cummings GE; El Sahly HM; Virk MK; Moffett BS; Morris Daniel JL; Watanabe A; Fishbane N; Kotloff KL; Gu K; Ghazaryan V; Gobburu JVS; Akcan-Arikan A; Campbell JD Crit Care Explor; 2024 Oct; 6(10):e1159. PubMed ID: 39352409 [TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury during vancomycin therapy in critically ill children. Totapally BR; Machado J; Lee H; Paredes A; Raszynski A Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections. Adane ED; Herald M; Koura F Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478 [TBL] [Abstract][Full Text] [Related]
17. The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients. Chen J; Huang X; Bu S; Chen X; Zhou J; Liu X; Guo X; Li L; Zhang J Pharmacol Res Perspect; 2021 Dec; 9(6):e00885. PubMed ID: 34664790 [TBL] [Abstract][Full Text] [Related]
18. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients. Chaijamorn W; Jitsurong A; Wiwattanawongsa K; Wanakamanee U; Dandecha P Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256 [TBL] [Abstract][Full Text] [Related]
19. [Vancomycin: what dosages are needed to achieve efficacy in paediatric hematology/oncology?]. Zegbeh H; Bleyzac N; Berhoune C; Bertrand Y Arch Pediatr; 2011 Aug; 18(8):850-5. PubMed ID: 21664803 [TBL] [Abstract][Full Text] [Related]
20. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients. Ocampos-Martinez E; Penaccini L; Scolletta S; Abdelhadii A; Devigili A; Cianferoni S; de Backer D; Jacobs F; Cotton F; Vincent JL; Taccone FS Int J Antimicrob Agents; 2012 Apr; 39(4):332-7. PubMed ID: 22333933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]